Manipal Health Enterprises has set the price band for its initial public offering at ₹560 to ₹590 per share, crystallizing the valuation framework for its public debut later this month.
The pricing decision places a significant premium on the company’s market position, testing investor appetite in a segment where valuations have come under scrutiny.
Profit after tax expanded at a 31% CAGR to ₹916 crore during the same period, underpinning the management’s confidence in the premium ask.
The offering comes as the healthcare operator reports robust financial momentum.
Over the last three fiscal years, the company has delivered a compound annual growth rate of 29% in revenue, reaching ₹10,335 crore in FY26.
Profit after tax expanded at a 31% CAGR to ₹916 crore during the same period, underpinning the management’s confidence in the premium ask.
However, the high entry price reflects the market’s skepticism regarding acquisition-driven expansion models.